0001292519-22-000001.txt : 20221014
0001292519-22-000001.hdr.sgml : 20221014
20221014161128
ACCESSION NUMBER: 0001292519-22-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20221014
DATE AS OF CHANGE: 20221014
EFFECTIVENESS DATE: 20221014
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: INVIVO THERAPEUTICS HOLDINGS CORP.
CENTRAL INDEX KEY: 0001292519
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-461817
FILM NUMBER: 221311483
BUSINESS ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BUILDING 1400 EAST 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-863-5524
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BUILDING 1400 EAST 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Design Source, Inc.
DATE OF NAME CHANGE: 20040602
D
1
primary_doc.xml
X0708
D
LIVE
0001292519
INVIVO THERAPEUTICS HOLDINGS CORP.
ONE KENDALL SQUARE
Suite B14402
CAMBRIDGE
MA
MASSACHUSETTS
02139
617-863-5524
NEVADA
Design Source, Inc.
Corporation
true
Richard
Toselli
One Kendall Square
Suite B14402
Cambridge
MA
MASSACHUSETTS
02139
Executive Officer
Director
Richard
Christopher
One Kendall Square
Suite B14402
Cambridge
MA
MASSACHUSETTS
02139
Executive Officer
C.
Ann
Merrifield
One Kendall Square
Suite B14402
Cambridge
MA
MASSACHUSETTS
02139
Director
Daniel
Marshak
One Kendall Square
Suite B14402
Cambridge
MA
MASSACHUSETTS
02139
Director
Christina
Morrison
One Kendall Square
Suite B14402
Cambridge
MA
MASSACHUSETTS
02139
Director
Richard
Roberts
One Kendall Square
Suite B14402
Cambridge
MA
MASSACHUSETTS
02139
Director
Robert
Rosenthal
One Kendall Square
Suite B14402
Cambridge
MA
MASSACHUSETTS
02139
Director
Heather
Hamel
One Kendall Square
Suite B14402
Cambridge
MA
MASSACHUSETTS
02139
Executive Officer
Biotechnology
Decline to Disclose
- 06b
false
2022-10-11
false
true
true
false
0
H.C. Wainwright & Co., LLC
375
None
None
430 Park Avenue
4th Floor
New York
NY
NEW YORK
10022
NY
NEW YORK
false
6249999
6249999
0
Private Placement of (i) pre-funded warrants to purchase up to 1,190,476 shares of common stock for a purchase price of $5.2499 per pre-funded warrant and (ii) preferred investment options to purchase up to 1,714,286 shares of common stock
false
1
531250
0
0
false
INVIVO THERAPEUTICS HOLDINGS CORP.
/s/ Richard Christopher
Richard Christopher
Chief Financial Officer
2022-10-14